Greater collaboration between ICU nurses and ICU physicians may minimize VAP risk The Challenge. The Evidence. The Solution. Ventilator Associated Pneumonia (VAP) remains a serious clinical issue in UK ICUs with NHS England data estimating 3,0006,000 deaths per year and treatment costs of 10,00020,000 Hospital acquired pneumonia (HAP) and ventilator associated pneumonia (VAP) are prevalent healthcare associated infections worldwide, with varying rates across countries. The emergence of Pfizer Medical What are the diagnostic criteria for ventilator associated pneumonia (VAP)? Ventilator associated pneumonia: mechanisms, an appraisal of current therapies and the role for inhaled antibiotics in prevention and treatment Respiratory Medicine Ventilator Associated Pneumonia HAIAR